{"groups":[{"description":"0.8 mg/kg subcutaneously weekly for 90 days","id":"FG000","title":"Etanercept"}],"periods":[{"dropWithdraws":[{"reasons":[{"groupId":"FG000","numSubjects":"1"}],"type":"Adverse Event"}],"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"1"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"0"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"1"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}],"preAssignmentDetails":"Study was terminated due to low accrual.","recruitmentDetails":"Recruitment Period: 05/19/04 through 03/05/09. All participants recruited at UT MD Anderson Cancer Center."}